Beneficial effects of butyrate in intestinal injury

Experimental study demonstrates that low-dose butyrate (1mM in vitro, 150mM enema in vivo) protects against necrotizing enterocolitis in neonatal mice by reducing inflammation and strengthening intestinal barrier function, while high doses cause injury. Findings suggest butyrate's therapeutic potential is dose-dependent.